Muscular Dystrophy UK

Last updated

About

Muscular Dystrophy UK
Formation1959
Registration no.205395
FocusMedical research, patient support
Headquarters Southwark, London, United Kingdom
President
Gabby Logan
Website https://www.musculardystrophyuk.org/
Formerly called
Muscular Dystrophy Group Muscular Dystrophy Campaign

Muscular Dystrophy UK (MDUK) [1] is a UK charity focusing on muscular dystrophy and related conditions. It works on behalf of those with over 60 muscle wasting and weakening conditions. For over 60 years, Muscular Dystrophy UK has been building a community of individuals living with muscle wasting or weakening conditions, families and carers, scientists, health care professionals, supporters, volunteers, and donors. Making advances that would have been unthinkable just ten years ago.

Contents

History

The charity was founded in 1959 (then known as the Muscular Dystrophy Group and later as the Muscular Dystrophy Campaign) by Lord Walton of Detchant, to help families and children living with muscular dystrophy, and to raise money to fund research to find the causes of and cures for muscular dystrophy.

Since then, diagnosis of the different forms of muscular dystrophy and related muscle conditions has improved hugely and the charity now provides support for more than 60 different muscle-wasting conditions, as well as funding many key research developments.

High Profile Supporters

Gabby Logan became President of the charity in 2018, taking over from Sue Barker who had held the role since 2004. Gabby is an active supporter, attending many charity events including the charity's annual national conferences and the celebrity sports quiz at Lords Cricket Ground. In 2024 she took on the London Landmarks Half Marathon for the charity raising over £5,000 [2]

Lord Attenborough served as the charity's President for 30 years, until 2002, when he became an Honorary Life President. [3] Lord Attenborough remained an inspirational supporter of the charity and the Richard Attenborough Fellowship Fund has been established to honour his commitment to world-class research.

Sir Alex Ferguson is a long-standing Vice President of the charity having been introduced to MDUK by a friend whose son was affected by the condition. He has been involved in fundraising and events for over ten years.

Prince Philip became Patron of the charity in 1966. Introduced to the charity by Lord Attenborough, he remained as Royal Patron until his sad passing in April 2021.

Fundraising

The majority of the charity’s work is funded by voluntary activity often carried about by those that are affected by muscular dystrophy.

Key events for the charity are the Microscope Ball which will be in its 40th year in 2024, an event attend by more than 700 members of the commercial property industry; Peddle, Paddle Peak [4] – the charity’s own off road challenge event and the Town and Gown 10K [5] series which takes place in Oxford and Cambridge each year.

In 2024 Muscular Dystrophy UK won funding from Project Giving Back to have a garden at the RHS Chelsea Flower Show. The garden at RHS Chelsea Flower show was designed by award winning designer, Ula Maria and based on the theme of Shirin-yoku the Japanese practice of Forest Bathing. This prestigious event marks a huge moment in the charity’s history.

Related Research Articles

<span class="mw-page-title-main">Muscular dystrophy</span> Genetic disorder

Muscular dystrophies (MD) are a genetically and clinically heterogeneous group of rare neuromuscular diseases that cause progressive weakness and breakdown of skeletal muscles over time. The disorders differ as to which muscles are primarily affected, the degree of weakness, how fast they worsen, and when symptoms begin. Some types are also associated with problems in other organs.

<span class="mw-page-title-main">Limb–girdle muscular dystrophy</span> Medical condition

Limb–girdle muscular dystrophy (LGMD) is a genetically heterogeneous group of rare muscular dystrophies that share a set of clinical characteristics. It is characterised by progressive muscle wasting which affects predominantly hip and shoulder muscles. LGMD usually has an autosomal pattern of inheritance. It currently has no known cure or treatment.

<span class="mw-page-title-main">Atrophy</span> Partial or complete wasting away of a part of the body

Atrophy is the partial or complete wasting away of a part of the body. Causes of atrophy include mutations, poor nourishment, poor circulation, loss of hormonal support, loss of nerve supply to the target organ, excessive amount of apoptosis of cells, and disuse or lack of exercise or disease intrinsic to the tissue itself. In medical practice, hormonal and nerve inputs that maintain an organ or body part are said to have trophic effects. A diminished muscular trophic condition is designated as atrophy. Atrophy is reduction in size of cell, organ or tissue, after attaining its normal mature growth. In contrast, hypoplasia is the reduction in the cellular numbers of an organ, or tissue that has not attained normal maturity.

<span class="mw-page-title-main">Gabby Logan</span> Welsh TV/radio presenter and rhythmic gymnast (born 1973)

Gabrielle Nicole Logan is a Welsh television and radio presenter, and a former rhythmic gymnast who represented Wales and Great Britain. She hosted Final Score for BBC Sport from 2009 until 2013. She has also presented live sports events for the BBC, including a revived episode of Superstars in December 2012 and the London Marathon since 2015. Since 2013, she has co-hosted Sports Personality of the Year for the BBC and she presented the second series of The Edge in 2015.

Muscular Dystrophy Association (MDA) is an American nonprofit organization dedicated to supporting people living with muscular dystrophy, ALS, and related neuromuscular diseases. Founded in 1950 by Paul Cohen, who lived with muscular dystrophy, MDA accelerates research, advances care, and works to empower families to live longer and more independent lives. Renowned for The MDA Labor Day Telethon, the annual telecast aired live from 1966 to 2010 and was hosted by Jerry Lewis, who also served as MDA's national chairman.

<span class="mw-page-title-main">Duchenne muscular dystrophy</span> Type of muscular dystrophy

Duchenne muscular dystrophy (DMD) is a severe type of muscular dystrophy predominantly affecting boys. The onset of muscle weakness typically begins around age four, with rapid progression. Initially, muscle loss occurs in the thighs and pelvis, extending to the arms, which can lead to difficulties in standing up. By the age of 12, most individuals with Duchenne muscular dystrophy are unable to walk. Affected muscles may appear larger due to an increase in fat content, and scoliosis is common. Some individuals may experience intellectual disability, and females carrying a single copy of the mutated gene may show mild symptoms.

In medicine, myopathy is a disease of the muscle in which the muscle fibers do not function properly. Myopathy means muscle disease. This meaning implies that the primary defect is within the muscle, as opposed to the nerves or elsewhere.

Muscular Dystrophy Canada (MDC) is a non-profit organization that strives to find a cure for neuromuscular disorders. Founded in 1954 as Muscular Dystrophy Association of Canada, volunteers and staff nationwide have helped to provide support and resources to those affected. Since the founding year, over $64 million has been put towards research via collaborations, fundraising events, and donations.

<span class="mw-page-title-main">Facioscapulohumeral muscular dystrophy</span> Medical condition

Facioscapulohumeral muscular dystrophy (FSHD) is a type of muscular dystrophy, a group of heritable diseases that cause degeneration of muscle and progressive weakness. Per the name, FSHD tends to sequentially weaken the muscles of the face, those that position the scapula, and those overlying the humerus bone of the upper arm. These areas can be spared, and muscles of other areas usually are affected, especially those of the chest, abdomen, spine, and shin. Almost any skeletal muscle can be affected in advanced disease. Abnormally positioned, termed 'winged', scapulas are common, as is the inability to lift the foot, known as foot drop. The two sides of the body are often affected unequally. Weakness typically manifests at ages 15 – 30 years. FSHD can also cause hearing loss and blood vessel abnormalities at the back of the eye.

<span class="mw-page-title-main">Congenital muscular dystrophy</span> Medical condition

Congenital muscular dystrophies are autosomal recessively-inherited muscle diseases. They are a group of heterogeneous disorders characterized by muscle weakness which is present at birth and the different changes on muscle biopsy that ranges from myopathic to overtly dystrophic due to the age at which the biopsy takes place.

<span class="mw-page-title-main">Muscle atrophy</span> Medical condition

Muscle atrophy is the loss of skeletal muscle mass. It can be caused by immobility, aging, malnutrition, medications, or a wide range of injuries or diseases that impact the musculoskeletal or nervous system. Muscle atrophy leads to muscle weakness and causes disability.

<span class="mw-page-title-main">Emery–Dreifuss muscular dystrophy</span> Medical condition

Emery–Dreifuss muscular dystrophy (EDMD) is a type of muscular dystrophy, a group of heritable diseases that cause progressive impairment of muscles. EDMD affects muscles used for movement, causing atrophy, weakness and contractures. It almost always affects the heart, causing abnormal rhythms, heart failure, or sudden cardiac death. It is rare, affecting 0.39 per 100,000 people. It is named after Alan Eglin H. Emery and Fritz E. Dreifuss.

<span class="mw-page-title-main">Winged scapula</span> Skeletal muscle condition around the shoulder blade

A winged scapula is a skeletal medical condition in which the shoulder blade protrudes from a person's back in an abnormal position.

<span class="mw-page-title-main">SGCG</span> Protein-coding gene in the species Homo sapiens

Gamma-sarcoglycan is a protein that in humans is encoded by the SGCG gene. The α to δ-sarcoglycans are expressed predominantly (β) or exclusively in striated muscle. A mutation in any of the sarcoglycan genes may lead to a secondary deficiency of the other sarcoglycan proteins, presumably due to destabilisation of the sarcoglycan complex. The disease-causing mutations in the α to δ genes cause disruptions within the dystrophin-associated protein (DAP) complex in the muscle cell membrane. The transmembrane components of the DAP complex link the cytoskeleton to the extracellular matrix in adult muscle fibres, and are essential for the preservation of the integrity of the muscle cell membrane.

<span class="mw-page-title-main">Camptocormia</span> Symptom of a multitude of diseases, most commonly seen in the elderly

Camptocormia, also known as bent spine syndrome (BSS), is a symptom of a multitude of diseases that is most commonly seen in the elderly. It is identified by an abnormal thoracolumbar spinal flexion, which is a forward bending of the lower joints of the spine, occurring in a standing position. In order to be classified as BSS, the anterior flexion must be of 45 degrees anteriorly. This classification differentiates it from a similar syndrome known as kyphosis. Although camptocormia is a symptom of many diseases, there are two common origins: neurological and muscular. Camptocormia is treated by alleviating the underlying condition causing it through therapeutic measures or lifestyle changes.

<span class="mw-page-title-main">Richard Attenborough</span> British actor (1923–2014)

Richard Samuel Attenborough, Baron Attenborough, was an English actor, film director, and producer.

Victor Dubowitz, FRCP, Hon FRCPCH is a British neurologist and professor emeritus at Imperial College London. He is principally known along with his wife Lilly Dubowitz for developing two clinical tests, the Dubowitz Score to estimate gestational age and the other for the systematic neurological examination of the newborn.

<span class="mw-page-title-main">Acceleron Pharma</span> American healthcare company

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

Mary M. Reilly FRCP is an Irish neurologist who works at National Hospital for Neurology and Neurosurgery. She studies peripheral neuropathy. She is the President of the Association of British Neurologists.

<span class="mw-page-title-main">David Gardner-Medwin</span> British neurologist who worked in Newcastle upon Tyne

David Gardner-Medwin was a British physician who worked as a paediatric neurologist in Newcastle upon Tyne, serving as the only neurologist for children for a population of 3.5 million. He is credited with introducing multidisciplinary care to the management of boys with Duchenne muscular dystrophy (DMD). When he retired at the age of 60, four consultants were appointed to replace him.

References

  1. "MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND - Charity 205395". register-of-charities.charitycommission.gov.uk. Retrieved 13 April 2024.
  2. "I am running for Muscular Dystrophy UK". JustGiving. Retrieved 13 April 2024.
  3. "Richard Attenborough Fellowship Fund". Muscular-dystrophy.org. Archived from the original on 5 November 2014. Retrieved 24 August 2014.
  4. "Pedal Paddle Peak 2024 - The Lake District | Muscular Dystrophy UK". www.musculardystrophyuk.org. Retrieved 13 April 2024.
  5. "Home - Town & Gown 10k | Muscular Dystrophy UK" . Retrieved 13 April 2024.